Author:
Mauskopf Josephine,Annemans Lieven,Hill Andrew M.,Smets Erik
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference66 articles.
1. US Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents (USDHHS). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents; 2008 Jan 29 [online]. Available from URL: (http://AIDSinfo.nih.gov) [Accessed 2009 Dec 10]
2. Ghatnekar O, Hjortsberg C, Gisslén M, et al. Medical resource utilization and cost of HIV-related care in the highly active antiretroviral therapy era at a university clinic in Sweden. PharmacoEconomics 2010; 28 Suppl. 1: 49–57
3. Levy A, Johnston K, Annemans L, et al. The impact of disease stage on direct medical costs of HIV management: a review of the international literature. PharmacoEconomics 2010; 28 Suppl. 1: 35–47
4. Colin X, Lafuma A, Costagliola D, et al. Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France. PharmacoEconomics 2010; 28 Suppl. 1: 183–97
5. Mauskopf JA, Kitahata M, Kauf T, et al. HIV antiretroviral treatment: early versus later. J Acquir Immune Defic Syndr 2005; 39: 562–9
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献